OPTIMIZATION OF ANTI-TUBERCULOSIS STRATEGY BY ADAPTATION OF VIDEO-OBSERVED TREATMENT FOR PULMONARY TUBERCULOSIS IN UZBEKISTAN
Keywords:
Pulmonary tuberculosis treatment monitoring, directly observed treatment, video-observed treatment, quality of life.Abstract
The development of drug-resistant forms of tuberculosis is the main drawback of monitoring the ongoing anti-tuberculosis treatment, which plays a significant role in planning measures to control of tuberculosis infection.
References
Баласанянц Г.С., Божков И.А., Торкатюк Е.А. Противотуберкулезные мероприятия как основа профилактики инвалидности при туберкулезе. Современные проблемы здравоохранения и медицинской статистики. 2024; 5: 1 – 18. DOI: 10.24412/2312-2935-2024-5-1-18
Викторова И.Б., Дегтярева С.Ю., Кулабухова Е.И. и др. Обнаружение Mycobacterium tuberculosis в мокроте у больных коинфекцией ВИЧ/туберкулез различными методами (обзор литературы). Журнал инфектологии. 2018; 10(2): 30 – 38. DOI: 10.22625/2072-6732-2018-10-2-30-38
Карпов О.Э., Субботин С.А., Шишканов Д.В. и др. Цифровое здравоохранение. Необходимость и предпосылки. Врач и информационные технологии. 2017; 3: С. 6 – 22. https://cyberleninka.ru/article/n/tsifrovoe-zdravoohranenie-neobhodimost-i-predposylki
Никитин П.В. Мурадянц А.А., Шостак Н.А. Мобильное здравоохранение: возможности, проблемы, перспективы. Клиницист. 2015; 9(4): 13 – 21. DOI: 10/17650/1818-8338-2015-9-4-13-21
Павлюченкова Н.А., Васильева И.А., Самойлова А.Г. и др. Видеоконтролируемое лечение – инновационный метод мониторинга терапии туберкулеза в условиях ограниченных ресурсов системы здравоохранения. Туберкулёз и болезни лёгких. 2022; 100(2): 53 – 60. DOI: 10.21292/2075-1230-2022-100-2-53-60
Тлаис Х., Анаев Э.Х., Княжеская Н.П., Щелыкалина С.П., Белевский А.С. Особенности течения хронической обструктивной болезни легких у пациентов с туберкулезом легких и ВИЧ-инфекцией. Пульмонология. 2024;34(6):822-831. DOI: 10.18093/0869-0189-2024-34-6-822-831
European Centre for Disease Prevention and Control. Guidance on tuberculosis control in vulnerable and hard-to-reach populations. Stockholm: ECDC (2016). Available at: https://www.ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/TB-guidance-interv entions-vulnerable-groups.pdf. [Accessed 4 January, 2020].
Gadoev J, Asadov D, Harries AD et al. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan. PLoSONE. 2017; 12(5): e0176473. DOI: 10.1371/journal.pone.0176473
Garfein R. S., Doshi R. P. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. J. Clin. Tuberc. Other Mycobact. Dis. 2019; 17: 100098. DOI: 10.1016/j.jctube.2019.100098
Idayat, M.; von der Lippe, E.; Kozhekenova, N.; Amartsengel, O. et al. Prevalence of Tuberculosis in Central Asia and Southern Caucasus: A Systematic Literature Review. Diagnostics. 2025; 15: 2314. DOI: 10.3390/diagnostics15182314
Pettit A. C., Jenkins C. A., Blevins Peratikos M. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. J. Int. AIDS Soc. 2019; 22(12): 25423. DOI: 10.1002/jia2.25423
TB incidence estimates for the Sustainable Development Goal and End TB Strategy 2025 milestone and 2030 targets assessment: data sources, analytical methods and process. Background document 3 for meeting of WHO Global Task Force on TB Impact Measurement, 25–27 September 2024. Geneva: World Health Organization; 2024 (https://cdn.who.int/media/docs/default-source/hq-tuberculosis/global-task-force-on-tb-impact-measurement/meetings/2024-09/background-documents/background1-tbincidenceestimates.pdf?sfvrsn=ee240ead_11).
Trubnikov, A.; Hovhannesyan, A.; Akopyan, K. et al. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis. Int. J. Environ. Res. Public Health. 2021; 18: 4121. DOI: 10.3390/ijerph18084121
World Health Organization. Global Tuberculosis Report. 2024. Available online: https://www.who.int/teams/globalprogramme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024 (accessed on 31 August 2025).
World Health Organization. Digital health for the end TB strategy: an agenda for action (2015). Available at: https://www.who.int/tb/areas-of-work/digital-health/Digital_health_EndTBstrategy.pdf. [Accessed 4 January, 2020].
World Health Organization. From innovation to implementation – eHealth in the WHO European Region (2016). Available at: http://www.euro.who.int/__data/assets/pdf_file/0012/302331/From-Innovation-to-Implementation-eHealth-Report-EU.pdf. [Accessed 4 January, 2020].
World Health Organization. Global tuberculosis report 2019. Licence: CC BY-NC-SA 3.0 IGO (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. [Accessed 4 January, 2020].
World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Available at: https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf?sequence=1. [Accessed 4 January, 2020].
World Health Organization. mHealth: new horizons for health through mobile technologies: second global survey on eHealth (2013). Available at: https://extranet.who.int/iris/restricted/bitstream/handle/10665/87688/9789244564257_rus.pdf?sequence=1&isAllowed=y. [Accessed 4 January, 2020].
World Health Organization. The END TB Strategy (2014). Available at: https://www.who.int/tb/strategy/End_TB_Strategy.pdf. [Accessed 4 January, 2020].
World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf. [Accessed 4 January, 2020].
Yuldashev, S.; Parpieva, N.; Alimov, S. et al. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track? Int. J. Environ. Res. Public Health. 2021; 18: 4685. DOI: 10.3390/ijerph18094685
Downloads
Published
Issue
Section
How to Cite
